Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient

Alain Zingraff Lekoubou Looti, A. E. Kouamé-Assouan, T. H. Cho, J. Luauté, N. Nighoghossian, L. Derex

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Introduction: Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a maternally-inherited multisystem disorder. Mitochondrial angiopathy mediated by nitric oxide, a metabolite of L-arginine, is among the proposed pathophysiologic mechanisms of stroke-like episodes (SLEs) in MELAS. There are very few reports on long-term prevention of SLEs with oral L-arginine and idebenone treatment in MELAS adult patients. Case report: A 38-year-old patient with MELAS and SLEs was treated with oral L-arginine and idebenone for 27 months. She remained free of attacks throughout the treatment period except when she stopped her treatment on two occasions during which she had recurrent cerebral metabolic attacks. The patient experienced no side effect of treatment with L-arginine and idebenone. Conclusion: Our observation suggests long-term safety and potential benefit of oral L-arginine and idebenone in the prevention of recurrence of SLEs in adult MELAS patients.

Original languageEnglish (US)
Pages (from-to)852-855
Number of pages4
JournalRevue Neurologique
Volume167
Issue number11
DOIs
StatePublished - Nov 1 2011

Fingerprint

Lactic Acidosis
Arginine
Stroke
Therapeutics
Mitochondrial encephalopathy
idebenone
Nitric Oxide
Observation
Safety
Recurrence

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Lekoubou Looti, Alain Zingraff ; Kouamé-Assouan, A. E. ; Cho, T. H. ; Luauté, J. ; Nighoghossian, N. ; Derex, L. / Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient. In: Revue Neurologique. 2011 ; Vol. 167, No. 11. pp. 852-855.
@article{405cd94296b54b6289dfea355a74c209,
title = "Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient",
abstract = "Introduction: Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a maternally-inherited multisystem disorder. Mitochondrial angiopathy mediated by nitric oxide, a metabolite of L-arginine, is among the proposed pathophysiologic mechanisms of stroke-like episodes (SLEs) in MELAS. There are very few reports on long-term prevention of SLEs with oral L-arginine and idebenone treatment in MELAS adult patients. Case report: A 38-year-old patient with MELAS and SLEs was treated with oral L-arginine and idebenone for 27 months. She remained free of attacks throughout the treatment period except when she stopped her treatment on two occasions during which she had recurrent cerebral metabolic attacks. The patient experienced no side effect of treatment with L-arginine and idebenone. Conclusion: Our observation suggests long-term safety and potential benefit of oral L-arginine and idebenone in the prevention of recurrence of SLEs in adult MELAS patients.",
author = "{Lekoubou Looti}, {Alain Zingraff} and Kouam{\'e}-Assouan, {A. E.} and Cho, {T. H.} and J. Luaut{\'e} and N. Nighoghossian and L. Derex",
year = "2011",
month = "11",
day = "1",
doi = "10.1016/j.neurol.2011.02.038",
language = "English (US)",
volume = "167",
pages = "852--855",
journal = "Revue Neurologique",
issn = "0035-3787",
publisher = "Elsevier Masson",
number = "11",

}

Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient. / Lekoubou Looti, Alain Zingraff; Kouamé-Assouan, A. E.; Cho, T. H.; Luauté, J.; Nighoghossian, N.; Derex, L.

In: Revue Neurologique, Vol. 167, No. 11, 01.11.2011, p. 852-855.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient

AU - Lekoubou Looti, Alain Zingraff

AU - Kouamé-Assouan, A. E.

AU - Cho, T. H.

AU - Luauté, J.

AU - Nighoghossian, N.

AU - Derex, L.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Introduction: Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a maternally-inherited multisystem disorder. Mitochondrial angiopathy mediated by nitric oxide, a metabolite of L-arginine, is among the proposed pathophysiologic mechanisms of stroke-like episodes (SLEs) in MELAS. There are very few reports on long-term prevention of SLEs with oral L-arginine and idebenone treatment in MELAS adult patients. Case report: A 38-year-old patient with MELAS and SLEs was treated with oral L-arginine and idebenone for 27 months. She remained free of attacks throughout the treatment period except when she stopped her treatment on two occasions during which she had recurrent cerebral metabolic attacks. The patient experienced no side effect of treatment with L-arginine and idebenone. Conclusion: Our observation suggests long-term safety and potential benefit of oral L-arginine and idebenone in the prevention of recurrence of SLEs in adult MELAS patients.

AB - Introduction: Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a maternally-inherited multisystem disorder. Mitochondrial angiopathy mediated by nitric oxide, a metabolite of L-arginine, is among the proposed pathophysiologic mechanisms of stroke-like episodes (SLEs) in MELAS. There are very few reports on long-term prevention of SLEs with oral L-arginine and idebenone treatment in MELAS adult patients. Case report: A 38-year-old patient with MELAS and SLEs was treated with oral L-arginine and idebenone for 27 months. She remained free of attacks throughout the treatment period except when she stopped her treatment on two occasions during which she had recurrent cerebral metabolic attacks. The patient experienced no side effect of treatment with L-arginine and idebenone. Conclusion: Our observation suggests long-term safety and potential benefit of oral L-arginine and idebenone in the prevention of recurrence of SLEs in adult MELAS patients.

UR - http://www.scopus.com/inward/record.url?scp=81155134769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81155134769&partnerID=8YFLogxK

U2 - 10.1016/j.neurol.2011.02.038

DO - 10.1016/j.neurol.2011.02.038

M3 - Article

C2 - 21514942

AN - SCOPUS:81155134769

VL - 167

SP - 852

EP - 855

JO - Revue Neurologique

JF - Revue Neurologique

SN - 0035-3787

IS - 11

ER -